Swedish Pharmaceuticals & Biotech Profitable Climbers

Camurus

Market Cap: SEK 36.4b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 12.0b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

BioGaia

Market Cap: SEK 10.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

AddLife

Market Cap: SEK 18.4b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Vitrolife

Market Cap: SEK 17.8b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Swedish Orphan Biovitrum

Market Cap: SEK 115.0b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Swedencare

Market Cap: SEK 6.1b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.